• Consensus Rating: Buy
  • Consensus Price Target: $149.80
  • Forecasted Upside: 7.49 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
▼ -3.21 (-2.25%)

This chart shows the closing price for AME by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New AMETEK Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AME and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AME

Analyst Price Target is $149.80
▲ +7.49% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for AMETEK in the last 3 months. The average price target is $149.80, with a high forecast of $166.00 and a low forecast of $122.00. The average price target represents a 7.49% upside from the last price of $139.36.

This chart shows the closing price for AME for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 9 polled investment analysts is to buy stock in AMETEK. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/21/2022KeyCorpBoost TargetOverweight$145.00 ➝ $165.00Low
11/2/2022Morgan StanleyBoost TargetOverweight$137.00 ➝ $144.00Low
11/2/2022Royal Bank of CanadaBoost TargetOutperform$135.00 ➝ $136.00Low
11/2/2022MizuhoBoost TargetBuy$140.00 ➝ $145.00Low
10/24/2022Wells Fargo & CompanyLower TargetOverweight$180.00 ➝ $165.00Low
10/12/2022Morgan StanleyLower TargetOverweight$145.00 ➝ $137.00Low
8/9/2022DA DavidsonBoost Target$160.00N/A
8/3/2022Royal Bank of CanadaReiterated RatingOutperformLow
8/3/2022MizuhoBoost TargetBuy$135.00 ➝ $140.00N/A
8/3/2022Morgan StanleyBoost TargetOverweight$135.00 ➝ $145.00Low
7/19/2022Loop CapitalLower TargetBuy$170.00 ➝ $155.00Low
7/18/2022MizuhoLower TargetBuy$159.00 ➝ $135.00Low
7/11/2022Bank of AmericaDowngradeBuy ➝ Neutral$170.00 ➝ $122.00N/A
5/31/2022Morgan StanleyLower TargetOverweight$144.00 ➝ $135.00Medium
5/10/2022Robert W. BairdLower TargetNeutral$156.00 ➝ $140.00Medium
5/4/2022KeyCorpLower Target$155.00 ➝ $145.00Medium
3/18/2022KeyCorpLower TargetOverweight$160.00 ➝ $155.00High
1/14/2022Morgan StanleyLower TargetOverweight$159.00 ➝ $158.00High
12/16/2021MizuhoInitiated CoverageBuy$159.00High
12/13/2021Wolfe ResearchUpgradePeer Perform ➝ Outperform$162.00 ➝ $166.00High
11/22/2021Loop CapitalInitiated CoverageBuy$75.00Low
11/3/2021Morgan StanleyBoost TargetOverweight$154.00 ➝ $159.00Low
11/3/2021Royal Bank of CanadaBoost TargetOutperform$160.00 ➝ $164.00Medium
10/7/2021Morgan StanleyLower TargetOverweight$156.00 ➝ $154.00Low
8/5/2021Robert W. BairdUpgradeHoldLow
8/4/2021Morgan StanleyBoost TargetOverweight$151.00 ➝ $156.00Medium
8/4/2021Rosenblatt SecuritiesBoost TargetBuy$155.00 ➝ $160.00Medium
8/4/2021Wells Fargo & CompanyBoost TargetOverweight$170.00 ➝ $175.00Medium
8/4/2021KeyCorpBoost TargetOverweight$150.00 ➝ $160.00Medium
5/5/2021DA DavidsonBoost TargetBuy$135.00 ➝ $157.00Medium
5/5/2021KeyCorpBoost TargetOverweight$141.00 ➝ $150.00Low
5/5/2021Morgan StanleyBoost TargetOverweight$135.00 ➝ $151.00Low
5/5/2021Wells Fargo & CompanyBoost TargetOverweight$160.00 ➝ $170.00Low
4/20/2021Wells Fargo & CompanyBoost TargetPositive ➝ Overweight$140.00 ➝ $160.00Low
4/13/2021KeyCorpBoost TargetOverweight$140.00 ➝ $141.00Low
4/12/2021Morgan StanleyBoost TargetOverweight$133.00 ➝ $135.00Low
4/1/2021KeyCorpBoost TargetOverweight$131.00 ➝ $140.00Low
3/30/2021Rosenblatt SecuritiesBoost TargetBuy$140.00 ➝ $142.00Low
3/9/2021KeyCorpBoost TargetOverweight$130.00 ➝ $131.00High
2/9/2021DA DavidsonReiterated RatingBuyLow
2/5/2021Morgan StanleyBoost TargetOverweight$131.00 ➝ $133.00Low
11/23/2020Morgan StanleyBoost TargetOverweight$117.00 ➝ $131.00Low
11/13/2020KeyCorpBoost TargetPositive ➝ Overweight$118.00 ➝ $130.00Low
10/30/2020Rosenblatt SecuritiesBoost TargetBuy$125.00 ➝ $128.00Low
10/30/2020Morgan StanleyBoost TargetOverweight$112.00 ➝ $117.00Low
10/14/2020KeyCorpBoost TargetOverweight$112.00 ➝ $118.00Medium
10/13/2020Morgan StanleyBoost TargetOverweight$105.00 ➝ $112.00Low
8/7/2020Morgan StanleyBoost TargetOverweight$98.00 ➝ $105.00Low
8/5/2020Wells Fargo & CompanyBoost TargetOverweight$110.00 ➝ $115.00Medium
8/5/2020KeyCorpBoost TargetOverweight$100.00 ➝ $112.00Medium
8/4/2020Wells Fargo & CompanyReiterated RatingBuyMedium
7/14/2020Morgan StanleyBoost TargetOverweight$90.00 ➝ $98.00High
6/18/2020Rosenblatt SecuritiesBoost TargetBuy$92.00 ➝ $104.00Low
6/11/2020OppenheimerDowngradeOutperform ➝ Market PerformMedium
5/26/2020Bank of AmericaUpgradeNeutral ➝ Buy$100.00Medium
5/6/2020Robert W. BairdBoost TargetNeutral$80.00 ➝ $84.00Low
5/6/2020Wells Fargo & CompanyBoost TargetOverweight$90.00 ➝ $100.00Low
5/6/2020Morgan StanleyBoost TargetOverweight$82.00 ➝ $90.00Low
5/6/2020Rosenblatt SecuritiesInitiated CoverageBuy$92.00Low
4/19/2020Royal Bank of CanadaReiterated RatingBuyHigh
4/16/2020DA DavidsonReiterated RatingBuy$93.00High
4/15/2020Morgan StanleyBoost TargetOverweight$75.00 ➝ $82.00Medium
4/6/2020Rosenblatt SecuritiesReiterated RatingBuy$90.00High
4/3/2020DA DavidsonLower Target$115.00 ➝ $95.00Medium
3/30/2020KeyCorpLower TargetOverweight$110.00 ➝ $100.00Medium
3/17/2020Morgan StanleyLower TargetOverweight$107.00 ➝ $78.00Low
3/16/2020Wells Fargo & CompanyLower TargetOverweight$120.00 ➝ $95.00High
3/12/2020CowenUpgradeMarket Perform ➝ Outperform$100.00 ➝ $95.00High
2/10/2020Langenberg & CompanyDowngradeHold$100.00Medium
2/7/2020StephensBoost TargetOverweight$113.00 ➝ $115.00High
2/6/2020Robert W. BairdBoost TargetNeutral$96.00 ➝ $98.00Medium
1/31/2020Rosenblatt SecuritiesReiterated RatingBuy$114.00Low
1/16/2020Robert W. BairdDowngradeOutperform ➝ Neutral$96.00Low
1/14/2020Morgan StanleyLower TargetOverweight$109.00 ➝ $107.00Low
1/13/2020CowenDowngradeOutperform ➝ Market PerformLow
1/9/2020Wolfe ResearchDowngradeOutperform ➝ Peer PerformLow
1/2/2020Rosenblatt SecuritiesReiterated RatingBuy$115.00Low
12/11/2019Morgan StanleyBoost TargetOverweight$102.00 ➝ $109.00Medium
11/27/2019Gordon HaskettInitiated CoverageBuy$125.00Low
11/19/2019KeyCorpBoost TargetOverweight$100.00 ➝ $110.00High
11/19/2019Gordon HaskettInitiated CoverageBuy$125.00High
11/7/2019Rosenblatt SecuritiesInitiated CoverageBuy$115.00Low
11/1/2019Wolfe ResearchSet TargetBuy$100.00Medium
11/1/2019Morgan StanleySet TargetBuy$97.00 ➝ $102.00Low
10/11/2019Bank of AmericaDowngradeBuy ➝ Neutral$105.00 ➝ $95.00Low
9/30/2019Bank of AmericaSet TargetBuy$105.00High
7/31/2019Royal Bank of CanadaSet TargetBuy$95.00Medium
7/31/2019OppenheimerBoost TargetOutperform$94.00 ➝ $100.00Medium
7/31/2019KeyCorpBoost Target$94.00 ➝ $100.00Medium
7/31/2019Morgan StanleyBoost TargetOverweight$95.00 ➝ $97.00Medium
5/15/2019Berenberg BankInitiated CoverageBuy ➝ Buy$100.00Low
5/3/2019Morgan StanleySet TargetBuy$95.00Low
5/3/2019Vertical ResearchReiterated RatingBuyLow
5/2/2019BMO Capital MarketsBoost TargetOutperform ➝ Outperform$99.00 ➝ $101.00Low
5/2/2019DA DavidsonBoost TargetBuy$101.00Low
5/2/2019KeyCorpBoost TargetOverweight ➝ Overweight$86.00 ➝ $94.00Low
3/15/2019DA DavidsonBoost TargetBuy$92.00Low
1/29/2019BMO Capital MarketsReiterated RatingBuy$90.00Low
1/8/2019Wolfe ResearchUpgradeMarket Perform ➝ OutperformLow
1/6/2019StephensReiterated RatingBuy$79.00Low
12/19/2018Royal Bank of CanadaReiterated RatingBuy$82.00High
12/18/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$81.00 ➝ $85.00Medium
12/12/2018CowenReiterated RatingBuy$91.00High
11/19/2018StephensInitiated CoverageOverweight$87.00Medium
11/5/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$84.00 ➝ $81.00Medium
11/2/2018Robert W. BairdBoost TargetOutperform ➝ Outperform$82.00 ➝ $84.00N/A
11/2/2018BMO Capital MarketsLower TargetOutperform ➝ Outperform$93.00 ➝ $91.00N/A
8/12/2018CowenReiterated RatingBuy$85.00Low
8/1/2018OppenheimerBoost TargetOutperform$85.00 ➝ $90.00Low
8/1/2018Bank of AmericaBoost TargetBuy ➝ Buy$87.00 ➝ $91.00Low
8/1/2018BMO Capital MarketsBoost TargetOutperform ➝ Outperform$92.00 ➝ $93.00Low
8/1/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$79.00 ➝ $84.00Medium
8/1/2018Royal Bank of CanadaReiterated RatingBuy$86.00Medium
5/3/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$76.00 ➝ $79.00Low
5/3/2018BMO Capital MarketsBoost TargetOutperform ➝ Outperform$90.00 ➝ $92.00Low
4/12/2018DA DavidsonInitiated CoverageBuy$85.00Medium
2/7/2018Morgan StanleyBoost TargetEqual Weight ➝ Overweight$67.00 ➝ $76.00Low
2/2/2018BMO Capital MarketsBoost TargetOutperform ➝ Outperform$88.00 ➝ $90.00Low
2/2/2018KeyCorpBoost TargetOverweight ➝ Overweight$82.00 ➝ $86.00Medium
2/1/2018Stifel NicolausReiterated RatingBuy$92.00Low
1/26/2018BMO Capital MarketsReiterated RatingBuy$88.00Medium
1/19/2018KeyCorpReiterated RatingBuy$82.00Medium
1/18/2018Wells Fargo & CompanySet TargetBuy$80.00 ➝ $88.00Medium
12/22/2017CowenReiterated RatingBuy$80.00N/A
12/21/2017OppenheimerReiterated RatingBuy$75.00Low
12/11/2017BMO Capital MarketsReiterated RatingBuy$80.00Low
12/11/2017Stifel NicolausReiterated RatingBuyLow
(Data available from 11/28/2017 forward)

News Sentiment Rating

0.46 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 5 very positive mentions
  • 39 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 1 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 5 very positive mentions
  • 39 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 11 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 5 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 10 very positive mentions
  • 29 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Current Sentiment

  • 10 very positive mentions
  • 29 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets. This segment also provides power quality monitoring and metering devices, uninterruptible power supplies, programmable power equipment, electromagnetic compatibility test equipment, gas turbines, and environmental health and safety market sensors, dashboard instruments for heavy trucks and other vehicles, and instrumentation and controls for the food and beverage industries; and aircraft and engine sensors, monitoring systems, power supplies, fuel and fluid measurement systems, and data acquisition systems for the aerospace industry. Its EMG segment offers engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, automation, and other applications; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers. This segment also operates a network of aviation maintenance, repair, and overhaul facilities. In addition, the company offers clinical and educational communication solutions. AMETEK, Inc. was founded in 1930 and is headquartered in Berwyn, Pennsylvania.
Read More

Today's Range

Now: $139.36
Low: $138.88
High: $142.00

50 Day Range

MA: $126.00
Low: $111.81
High: $142.57

52 Week Range

Now: $139.36
Low: $106.17
High: $148.07


666,030 shs

Average Volume

1,061,018 shs

Market Capitalization

$32.00 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of AMETEK?

The following sell-side analysts have issued research reports on AMETEK in the last twelve months: Bank of America Co., DA Davidson, KeyCorp, Loop Capital, Mizuho, Morgan Stanley, Robert W. Baird, Royal Bank of Canada, StockNews.com, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for AME.

What is the current price target for AMETEK?

10 Wall Street analysts have set twelve-month price targets for AMETEK in the last year. Their average twelve-month price target is $149.80, suggesting a possible upside of 7.5%. Wolfe Research has the highest price target set, predicting AME will reach $166.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $122.00 for AMETEK in the next year.
View the latest price targets for AME.

What is the current consensus analyst rating for AMETEK?

AMETEK currently has 2 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AME will outperform the market and that investors should add to their positions of AMETEK.
View the latest ratings for AME.

What other companies compete with AMETEK?

How do I contact AMETEK's investor relations team?

AMETEK's physical mailing address is 1100 CASSATT ROAD, BERWYN PA, 19312. The technology company's listed phone number is (610) 647-2121 and its investor relations email address is [email protected] The official website for AMETEK is www.ametek.com. Learn More about contacing AMETEK investor relations.